Fondaparinux sodium injection
制剂 FDF · injection · 10mg/0.8ml； 7.5mg/0.6ml； 5mg/0.4ml； 2.5mg/0.5ml；
制剂 FDFConfidentiality：公开
- INN / Generic Name
- Fondaparinux sodium injection
- Dosage Form
- injection
- Strength
- 10mg/0.8ml； 7.5mg/0.6ml； 5mg/0.4ml； 2.5mg/0.5ml；
- Therapy Area
- Cardiovascular
- Indication
- Prevention of VTE in major lower limb orthopedic surgery; Treatment of deep vein thrombosis or pulmonary embolism; Treatment of unstable angina or NSTEMI not undergoing early PCI; Treatment of ST‑elevation MI undergoing thrombolysis or without initial reperfusion; Prophylaxis of VTE in acutely ill medical patients with reduced mobility
- Current Status
- 官方 FDF 授权目录（UB835）
- GMP Certification
- US - FDA
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- 已完成注册（目标市场可转移 / 视市场 DCP·NP）
- MOQ
- 询价
- Lead Time
- 询价
- Price Range
- 询价
Registrable Markets
United States
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price
- —